Meeting discusses possible export of coronavirus vaccines: Report

A multi-ministerial meeting on Monday discussed various aspects of India's possible export of COVID-19 vaccines in view of requests from an increasing number of countries to procure the vaccines, people familiar with the development said.

The issue was discussed extensively at the virtual meeting attended by representatives from various ministries and agencies, including the Department of Pharmaceuticals and the Ministry of External Affairs (MEA), they said.

They said the ministries of health, commerce, external affairs and the Department of Pharmaceuticals are among the key stakeholders involved in the possible export of the vaccines.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute of India, Covaxin is being produced by Bharat Biotech.

Several countries have approached India for the procurement of the vaccines. It is learnt that countries in India's neighbourhood are likely to get the supplies first.

On Thursday, MEA Spokesperson Anurag Srivastava said the government is assessing the production schedules and availability of the COVID-19 vaccines, and any decision on their supply to other countries "may take some time".

"In so far as requests from countries for vaccines from India, you would recall that Prime Minister (Narendra Modi) has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis," he had said at a media briefing.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel